CARAT: Clinical and Device Functional Assessment of Real World ICD Patients

Sponsor
MicroPort CRM (Industry)
Overall Status
Completed
CT.gov ID
NCT02341768
Collaborator
(none)
2,056
102
53.8
20.2
0.4

Study Details

Study Description

Brief Summary

The primary requirement of the implantable cardioverter defibrillator (ICD) is to preserve life by terminating life-threatening arrhythmias (VT/VF). The treatment options vary in terms of techniques and medical devices, based on the patient's condition.

It is extremely important in the clinical practice to identify which patients' subgroup benefits the most from the ICD therapy, which comorbidity has a major impact on the patients' prognosis, or which pre-intra-post procedural behaviors provoke less complications, and affect the patient's outcome (including prolonged or unwanted hospitalizations).

Condition or Disease Intervention/Treatment Phase
  • Device: ICD

Detailed Description

For these reasons, it is very important to observe the clinical practice on a large variety of centers and countries, with the objective to collect long term safety and performance data in patients undergoing ICD/CRT-D device implantation (first implant, replacement or upgrade).

The safety and performance of the ICDs can be evaluated through the collection of multiple parameters such as, but not limited to:

  • Clinical parameters, like patient demographics and history, procedural and hospital discharge data, as well as the short and long term serious adverse events (death and hospitalization)

  • Device parameters, such as delivered shocks, ATP, or other device therapies

Worldwide selected centers will be invited to participate in this prospective study and include their "real-world" patients treated with Sorin Group commercially available ICDs and CRT-Ds devices.

Study Design

Study Type:
Observational
Actual Enrollment :
2056 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Clinical and Device Functional Assessment of Real World ICD Patients
Actual Study Start Date :
Jun 1, 2015
Actual Primary Completion Date :
Nov 26, 2019
Actual Study Completion Date :
Nov 26, 2019

Outcome Measures

Primary Outcome Measures

  1. Evaluate clinical and device functional information from "real world" ICD patient population following standard of care at participating centers w/in the different participating countries (Incidence of all death, device,cardiac related hospitalization) [2 years]

    Incidence of all death, device and/or cardiac related hospitalization at 24 months post implant

Secondary Outcome Measures

  1. Serious procedural complications or other SAE at implantation or hospital discharge. The data analyzed are those collected from the day of implantation to the day of hospital discharge, with an expected average of 1 week. [at implantation or hospital discharge]

    as reported by the sites on the AE eCRF

  2. The incidence of all death, device and/or cardiac related hospitalization at 12 months post implant (evaluated with a survival curve) [at 12 months]

    as reported by the sites with AE

  3. The predictors of mortality and cardiac related hospitalization at 12 and 24 months [at 12 and 24 months]

    as reported by the sites with AE and medical history information

  4. The predictors of appropriate or inappropriate therapies (ATP and shocks) at 12 and 24 months, as verified by a dedicated committee [at 12 and 24 months]

    based on therapies delivered recorder on device file, and verified by a dedicated committee

  5. The evolution of the indication for implant according to guideline (based on the patient's medical history and reason for implant as reported by the investigators) [at implant]

    based on the patient's medical history and reason for implant as reported by the investigators

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient Implanted (first implant, replacement, upgrade) with a Sorin Group ICD/CRT-D device, according to current available guidelines and IFU

  • Signed and dated informed consent (in accordance to local regulation)

Exclusion Criteria:
  • Already included in another clinical study that could confound the results of this study

  • Not available for routine follow-up visits

  • Minor age

  • Drug addiction or abuse

Contacts and Locations

Locations

Site City State Country Postal Code
1 LKH Feldkirch Feldkirchen bei Mattighofen Austria
2 LKH Innsbruck Innsbruck Austria
3 Kepler Universitatsklinikum GmbH Linz Austria
4 LKH St. Polten Polten Austria
5 Sunnybrook Health Sciences Center Toronto Ontario Canada
6 Royal Alexandra Hospital Edmonton Canada
7 HDM (CHUM) Montreal Montreal Canada
8 HSCM Montreal Montreal Canada
9 IUCPQ Quebec Quebec Canada
10 Sherbrooke Quebec Canada
11 Fakultni Nemocnice Brno Brno Czechia
12 Fakultni Nemocnice U svaté Anny v Brno Brno Czechia
13 Fakultni Nemocnice Olomouc Olomouc Czechia
14 CHU Angers Angers France
15 CH Annecy Genevois Annecy France
16 Clinique Rhône Durance Avignon France
17 CHU de Bordeaux Bordeaux France
18 CHU de Brest Brest France
19 CHU de Caen Caen France
20 H.I.A Percy Clamart France
21 CHU de Clermont-Ferrand Clermont-Ferrand France
22 CHU Henri Mondor Créteil France
23 CHU de Grenoble Grenoble France
24 CH de Marne la Vallée Jossigny France
25 Hôpital Louis Pasteur Le Coudray France
26 CHRU de Lille Lille France
27 CH St Joseph St Luc Lyon France
28 Hôpital la Timone Marseille France
29 Hôpital Nord Marseille Marseille France
30 Hôpital Jacques Cartier Massy France
31 CHU A de Villeneuve Montpellier France
32 Clinique du Millénaire Montpellier France
33 CHRU de Nancy Nancy France
34 CHU de Nantes Nantes France
35 Nouvelles Cliniques Nantaises Nantes France
36 CHU de Nimes Nimes France
37 HEGP Paris 15 France
38 La Pitié Salpétrière Paris France
39 CHU François Mitterand Pau France
40 CH Perpignan Perpignan France
41 CHU de Poitiers Poitiers France
42 CHRU de Pontchaillou Rennes France
43 CHRU de Rouen Rouen France
44 CHU de Valence Valence France
45 CH de Villefranche sur Saone Villefranche sur Saone France
46 Kardiologische Praxis Altentreptow Germany
47 HGZ Bad Bevensen Bad Bevensen Germany
48 Herz- und Diabeteszentrum Bad Oeynhausen Germany
49 Evangelisches Krankenhaus Bielefeld Germany
50 Universitatskliniken Bonn Germany
51 Kardiologie Darmstadt Darmstadt Germany
52 Universitatskliniken Düsseldorf Düsseldorf Germany
53 Albertinen-Krankenhaus Hamburg Germany
54 Cardiologicum Hamburg Hamburg Germany
55 Universität Kiel Kiel Germany
56 Universitaetsklinikum Schleswig Holstein Lubeck Germany
57 Universitätsklinikum Magdeburg Magdeburg Germany
58 Kardiologische Praxis Markkleeberg Germany
59 Dietrich Bonhoeffer Klinikum Neubrandenburg Germany
60 Universitatsklinikum Wurzburg Germany
61 Ospedale Garibaldi Centro Catania Italy
62 Ospedale Pol SS Annunziata Chieti Italy
63 Presidio Ospedaliero di Chioggia Chioggia Italy
64 Ospital San Luca Lucca Italy
65 Ospedale Civile Mirano Italy
66 Osp S Giovanni Bosco Napoli Italy
67 Ospedale Cardarelli Napoli Italy
68 Ospedale Policlinico Federico II Napoli Italy
69 Policlinico Casilino Rome Italy
70 Osp. G. Mazzini Teramo Italy
71 Azienda Ospedaliero-Universitaria Ospedali Riuniti Trieste Italy
72 Vlietland Ziekenhuis Schiedam Netherlands
73 Isala Klinieken Zwolle Netherlands
74 Hospital Garcia de Orta Almada Portugal
75 Hospital Professor Doutor Fernando Fonseca Amadora Portugal
76 CHLC Hospital de Santa Marta Lisboa Portugal
77 H. Santa Maria Lisboa Portugal
78 Susch Hospital Banská Bystrica Slovakia
79 Nusch Hospital Bratislava Slovakia
80 Vusch Hospital Kosice Slovakia
81 Hospital Clínic de Barcelona Barcelona Spain
82 Hospital Virgen de las Nieves Granada Spain
83 Hospital Ramon y Cajal Madrid Spain
84 Hospital Universitario Clínico San Carlos Madrid Spain
85 Hospital Universitario Puerta de Hierro Majadahonda Spain
86 Hospital Universitario Virgen de la Victoria Malaga Spain
87 Hospital Central de Asturias Oviedo Spain
88 Hospital Son Llàtzer Palma de Mallorca Spain
89 Complejo Hospitalario Universitario Santiago de Compostela Spain
90 H.U La Fe Valencia Spain
91 CHU de Vigo Vigo Spain
92 Fondazione Cardiocentro Ticino Lugano Switzerland
93 Barnet General Hospital Barnet United Kingdom
94 Edgbaston Birmingham United Kingdom
95 Papworth Hospital NHS Foundation Trust Cambridge United Kingdom
96 Dorget County Hospital Dorchester United Kingdom
97 Royal Infirmary of Edinburgh Edinburgh United Kingdom
98 Wye Valley NHS Trust Hereford United Kingdom
99 Glenfield Hospital Leicester United Kingdom
100 King's College Hospital London United Kingdom
101 Northampton General Hospital Northampton United Kingdom
102 Northern General Hospital Sheffield United Kingdom

Sponsors and Collaborators

  • MicroPort CRM

Investigators

  • Principal Investigator: Javier Moreno, Dr, Hospital Ramón y Cajal Ctra. de Colmenar Viejo km 9.100, 28034 Madrid, Spain

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
MicroPort CRM
ClinicalTrials.gov Identifier:
NCT02341768
Other Study ID Numbers:
  • RTSY03
First Posted:
Jan 19, 2015
Last Update Posted:
Aug 17, 2020
Last Verified:
Aug 1, 2020
Keywords provided by MicroPort CRM
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 17, 2020